Hypertension remains a severe challenge to population health worldwide. This study assessed the impact of a nationwide program in China-Essential Public Health Services (EPHS) on improvement of hypertension treatment and control.
Original article
Cardiovascular disease (CVD) is a major cause of mortality and morbidity worldwide. 1 Hypertension, is a main target of intervention in reducing the burden of CVD, [2] [3] [4] [5] but serious disparities in the prevention, treatment, and control of hypertension exist in both developing and developed nations. [5] [6] [7] [8] The public and private sectors in different countries have launched various types of community-based hypertension control initiatives. 9, 10 Evaluating the effectiveness of these community-based prevention programs, however, remains a challenge due to the difficulty of linking the program attendance and the morbidity outcomes over time at the population level.
In China, the prevalence of hypertension has reached 29.6% nationally in 2014. 11, 12 Meanwhile, about 50% of hypertensive patients did not take any medication and about 80% did not have their hypertension under control. 13 Levels of hypertension control and treatment vary greatly across various geographic regions of the country. [14] [15] [16] The rate of treating hypertension with antihypertensive medications was observed higher in central and eastern regions and lower in western regions. 15 In 2009, the Chinese central government launched a national program, Essential Public Health Services (EPHS), with the objective of providing free essential public health services for all Chinese citizens. 17 The benefit package of the EPHS included physical examination, health education, immunization for infants and young children, maternal health management, chronic disease screening, and management. 18 To implement the EPHS program, the government provided a subsidy of 15 yuan (US $2.14) per capita for primary care providers to deliver the defined package. The goal of the EPHS was not only to reduce the disparities for the Chinese population in accessing essential public health services, but also to strengthen the role of health care systems in chronic disease prevention. From 2011 to 2013, an increased public funding (30 yuan per person, US $4.61) had been invested to expand the EPHS's services such as annual physical examination for all community residents aged 65 and older, regular health check-ups, and follow-up services for patients aged 35 and older with hypertension or type 2 diabetes. 18, 19 A recent cross-sectional analysis showed that the implementation of EPHS policy was followed by a substantial increase in the rates of self-reported hypertension control across different regions, from 8.3% in eastern regions, 7.6% in central regions, and 5.3% in western regions between 2005 and 2009 to 44% nationwide in 2013. 18 However, evidence is limited by the cross-sectional nature of the data and self-reported nature of the variable for hypertension control. This study used longitudinal data and objective measures of hypertension to examine whether receiving the EPHScovered physical examination was associated with successful hypertension control among the middle-aged and older adults nationwide and in different regions across the country.
METHODS

Data and sample
Data for this study were from the China Health and Retirement Longitudinal Study (CHARLS) 2011 and 2013, which interviewed a nationally representative sample of adults 45 years and older. 20 CHARLS respondents were followed every 2 years using a computer-aided personal interview. The national baseline survey of CHARLS was conducted between June 2011 and March 2012 and included 17,705 respondents from 10,257 households. A total of 15,020 (85.61%) respondents participated in a follow-up survey between July and August in 2013. This study used the de-identified database that was publicly available online. 21 The study sample was selected from respondents who provided biomarker information (e.g., blood pressure measures) in both 2011 and 2013, and had not received EPHS by the time of interview in 2011 (n = 12,759). Blood pressure was measured 3 times at 5-minute intervals using an Omron HEM-7200 Monitor during the day time. Respondents were asked to relax and remain seated when measured by professionals. The final blood pressure level was calculated by averaging these 3 measures. Hypertension was defined as (i) having an average systolic blood pressure of 140 mm Hg or higher or (ii) having an average diastolic blood pressure of 90 mm Hg or higher, or (iii) the respondent was currently taking antihypertensive medications (either Western or traditional Chinese medications) to manage hypertension condition. Our final sample consists of 4,958 respondents who had completed both surveys and provided complete data for all study variables (Figure 1 ).
Measurement
This study assessed the changes in the rate of hypertension control, medication use, and blood pressure monitoring at a doctor's office among this cohort between 2011 and 2013. Hypertension control was defined as respondents' average systolic blood pressure below 140 mm Hg and average diastolic blood pressure below 90 mm Hg from the blood pressure measures. The control rate in 2011 and 2013 were calculated as the percentage of hypertensive patients whose blood pressure was under control. The rate of taking antihypertension medications was calculated based on the percentage of respondents who reported taking medication to control high blood pressure in 2011 and 2013. Blood pressure monitoring was defined as respondents having blood pressure examined for at least once during the past 12 months. The rate of monitoring blood pressure was calculated by the percentage of respondents who reported having their blood pressure checked at a doctor's office in the past year.
The intervention under this study was EPHS-covered physical examination. We used the question "When did you take the last physical examination?" to identify persons who had taken a physical examination in 2012 or 2013, and then used the question "Who paid for your last physical examination?" and the self-reported answer "government-paid" as the measure for whether the hypertensive patient received the EPHS-covered physical examination service, because EPHS was expanded to pay for physical examination at least once a year for community residents ≥65 years and for those ≥35 years who had been diagnosed with hypertension. People who reported their physical examinations were paid by children, relatives, employers, insurance, themselves or others were grouped with those who did not receive any physical examination service, and served as the comparison.
Covariates were respondents' sociodemographic characteristics, including age, gender, educational attainment, household income, administrative registration status, marital status, residential region, insurance status, and diagnosed chronic diseases. Residential region was defined by where the respondents were living at the time of the survey and was categorized into 3 groups-Western China, Eastern China, and Central China-following the definition of the State Bureau of Statistics of China according to their level of socio-and economic development.
Statistical analysis
A difference-in-difference (DID) approach was applied to assess the treatment effects. The treatment group consisted of respondents received the EPHS-covered physical examination in 2012-2013, and the control group included those who did not attend an EPHS-covered physical examination. A time dummy indicated the fixed secular time trend in the treatment and control groups. And an interaction term between the intervention and time dummy represented the net effect of the policy impact on patient outcomes. The aforementioned covariates were adjusted in probit regressions. To account for individual interdependence within communities, community-level clustering was further adjusted in the model. This study also tested if residential region modified the effect of the policy on hypertension outcomes. Regression models were performed for each outcome first in the national cohort and then in the 3 subsamples stratified by regions. Finally, as a confirmatory analysis to address the possible impact of demographic differences between the treatment and control groups, we added propensity-score weighting to our DID analysis. All analyses were conducted in Stata 14.2 (StataCorp LP, College Station, TA).
RESULTS
Among those 4,958 hypertensive patients, 404 (8.1%) had received the EPHS-covered physical examination by 2013, while 4,554 (91.9%) had not. Table 1 presents the rates of hypertension treatment and control at the baseline year of 2011 and at the follow-up year of 2013. In 2011, the rate of hypertension control was similar in the treatment group and the control group; whereas in 2013, the rate of hypertension control was significantly higher in the treatment group (35.5% vs. 27.3 %, p<0.001). At baseline, the rate of antihypertensive medication use was close in the treatment and control groups; however, the rate was much higher in the treatment group in 2013 (61.3% vs. 50.0%, p<0.001). The rate of blood pressure monitoring was similar in the two groups at baseline, while it was substantially higher in the treatment group than in the control group in 2013 (65.0% vs. 50.9%, p<0.001).
By residential region, in Western China, the hypertension control rate was significantly higher in the treatment group than control group in 2011 (20.2% vs.12.9%, P = 0.043), but the difference between the two groups in 2013 was only marginally significant (37.4% vs. 28.5%, P = 0.063). In Central China, the rate of hypertension control was similar between the two groups at baseline (16.0% vs. 18.4%, P = 0.421) but was higher in the treatment group in 2013 (37.6% vs. 28.4%, p<0.009). In Eastern China, the rate of hypertension control was not significantly different in the 2 groups in 2011 (19.8% vs. 20.0%, P = 0.958) and in 2013 (30.9% vs. 25.2%, P = 0.156). Both the rates of medication use and blood pressure monitoring significantly increased in the treatment group in Western, Eastern, and Central China. Table 2 shows the sample characteristics by group and by respondents' residential region. In the national sample, hypertensive patients who reported having received the EPHS-covered physical examination were slightly older and more likely to have had some formal education (P < 0.05) than those who did not take a EPHS-covered physical examination. By residential region, the demographic characteristics were also similar between the treatment and the control groups; except that a higher percentage of rural and poor people received EPHS in Western China than that in Eastern and Central China. Table 3 presents the regression results from the DID analyses. The hypertension control rate has improved overall from 2011 to 2013, and in particular, it increased more in the treatment group than in the control group (risk difference [RD] = 7.9%, SE = 2.9%, P = 0.020). The improvement of medication use rate attributable to the treatment was 10.3% (SE = 2.5%, P < 0.001). As for rate of blood pressure monitoring, the increase attributable to the treatment was 10.5% (SE = 2.5%, P < 0.001) nationally.
A modification test showed that residential region modified the impact of the program on blood pressure monitoring (P = 0.015), with the EPHS-coverage showing a larger impact in the Western region. In Western China, the treatment did not significantly increase the rate of hypertension control, but increased the rate of medication use by 14.7% (SE = 5.4%, P = 0.007) and the rate of blood pressure monitoring by 17.6% (SE = 4.4%, P < 0.001). In Central China, the treatment contributed to a 11.7% (SE = 4.2%, P = 0.007) increase in the rate of hypertension control, an 7.4% (SE = 3.4%, P = 0.031) increase in the rate of medication use, and an 11.6% (SE = 3.6%, P = 0.002) increase in the rate of blood pressure monitoring. In Eastern China, the treatment significantly increased the rate of medication use (RD = 11.0%, SE = 4.8%, P = 0.022) but not blood pressure monitoring (RD = 3.9%, SE = 4.9%, P = 0.454) or hypertension control (RD = 5.9%, SE = 5.6%, P = 0.325).
We compared the propensity-score-weighted frequency distributions for the sample characteristics between the treatment and control groups and presented the comparison results in Supplementary Appendix Table S2 . The differences between the 2 groups were insignificant after propensityscore weighting. The DID estimates of the treatment effects after the propensity-score weighting were very similar to DID estimates we had without propensity-score weighting (Table 4) . So, we confirmed that the unbalance in demographic characteristics would not affect our analysis results.
DISCUSSION
The present study showed that the EPHS program had a significant impact on improving the rate of hypertension control, antihypertensive medication use, and physician's blood pressure monitoring. Evidence from the United States suggests that delivering free hypertension screening and counseling services to at-risk populations can efficiently reduce the burden of CVDs in a relatively short time and become cost-saving, 22 a relatively rare feature for chronic disease interventions. Thus, it is not surprising that this approach of delivering public-funded screening to the population at large in China was effective in hypertension control. Furthermore, the EPHS program might also have helped reduce the regional disparity in hypertension treatment across different regions, as in Western China this program increased medication use and blood pressure monitoring with effect sizes larger than those seen in Central China and Eastern China. These findings indicated that China's National EPHS program may have started to achieve its objective of reducing the geographic disparity in access to essential preventive services such as hypertension screening and treatment, as well as improving the community-based chronic disease management. A larger improvement of blood pressure monitoring was observed in western regions with relatively low economic development than in eastern and central regions. This may be due to the fact that during the recent years the central government has devoted more resources to these underdeveloped regions for managing chronic diseases. Other recent studies also reported a larger improvement of health record coverage and hypertension management in rural and poorer regions than in more affluent regions after the implementation of the EPHS program. 23, 24 Given the difficulty of changing individual behavior, population-level interventions with policy tools have been increasingly used to control hypertension around the world. The American Heart Association has published scientific statement that summarizes evidence of population-level interventions in improving cardiovascular health and preventing CVDs. The statement emphasizes the importance of providing adequate reimbursement for clinical preventive interventions. 25 In several other countries or regions, population-level interventions have also demonstrated effectiveness in controlling hypertension and CVD. For example, a nationwide hypertension control program in Japan that provided free screening and treatment of hypertension has resulted in 42-75% decrease in stroke incidence. 10 Taiwan's universal National Health Insurance has resulted in a significant population-wide improvement in hypertension control. 26 The broader international significance of our findings lies in the low-cost nature of the EPHS program: if a public health program with a cost between $2.41 and $4.61 per capita can achieve measurable improvement in population health within 4 years of implementation, decision makers in the public sector could see hypertension prevention and management as an affordable tool to reduce the health and economic burden of CVDs. One very important future study will be to examine whether EPHS is cost-saving by a Marginal differences of the predicted probabilities between the treatment and control groups were estimated from probit regressions, adjusting for age, gender, educational attainment, household income, administrative registration status, marital status, residential region, insurance status, chronic diseases diagnosis, and community-level clustering.
b Difference-in-difference estimate. *P < 0.05; **P < 0.01; ***P < 0.001. Meanwhile, the implementation of this EPHS program still has considerable room for improvement. Only 8.1% of the middle-aged and older population in our sample took this EPHS-covered physical examination between 2011 and 2013. This low reach of screening in our sample may be due to several reasons. First, it is likely that many patients were not diagnosed with hypertension and did not attend this screening service in their communities. It was reported that the prevalence of undiagnosed hypertension was around 50% among those hypertensive patients aged 45 or above in China. 13 To maximize the benefit of the EPHS policy, further implementation of EPHS should involve widespread public education about the benefits of chronic disease screening and management to strengthen residents' health consciousness and change their attitudes. Second, the shortage in public health and primary care workforce may contribute to the lack of delivery in preventive services such as hypertension screening and management. For example, home health visits were not available for most communities in China, and travel distance especially in rural and remote areas was a barrier for hypertensive patients to access essential preventive care. 19 Government funding has been very limited for rural health care providers. 27 However, as hypertension screening is viable through low-cost delivery approaches such as mobile health clinics and hypertension vans, 28 the local scarcity of health care working force should not deny the residents the chance to receive EPHS services.
This study has its limitations. First, measuring blood pressure for only 3 times may not accurately diagnose hypertension. The 24-hour ambulatory blood pressure monitoring is the best way to confirm hypertension diagnoses. 29 However, since CHARLS is a populationbased survey, ambulatory blood pressure monitoring measurement might be cost-inefficient and difficult to operationalize. Second, the measure on EPHS may contain recall bias. For example, some respondents may not recall the last time when they had a physical examination, or mistakenly reported government-paid physical examination as self-paid. The estimates could be biased toward either direction if this recall bias systematically correlates positively or negatively with the hypertension outcomes. Third, measurement error may occur in the responses to the questions on medication use and blood pressure monitoring. Fourth, EPHS provided free services for those aged 35 or above and our sample (from CHARLS) only included people aged 45 years or above. It was reported in 2010 that the age-specific hypertension prevalence was 13.0%, 36.7%, and 56.5% among persons aged 20 to 44 years, 45 to 64 years, and 65 years and older, respectively. 12 Thus, our study sample only represented the majority of the target population of EPHS and it did not represent the overall hypertensive population in China either. We will use nationally representative data to re-evaluate the policy impacts in the future. We are also aware that the sample size for Western China is small, which could contribute to the insignificant result about the hypertension control rate for that region. Finally, sample selection bias could be caused by missing values in the biomarker data or loss-to-follow-up. Among the hypertensive patients, 10.55% (588 of the 5,575) of the respondents contained missing values. We estimated whether the characteristics of those with and without missing values in key variables were significantly different and the results were provided in Supplementary Appendix Table  S1 . Compared with the sample without missing data, the sample with missing values was significantly older, less likely to be married and more likely to have no formal education. Some of these differences might cause biases in effect size estimation. Nevertheless, our confirmatory analysis showed that these biases may be small. In summary, this study suggests that expanding the Essential Public Health Services program may reduce the hypertension burden at the population level. In addition, this populationbased program may have narrowed the gaps in access to essential preventive services across various geographic regions. The effectiveness of the program may be bolstered by further public investment in the preventive services and enhancement of the public health and primary care workforce.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of Hypertension online. a Marginal differences of the predicted probabilities between the treatment and control groups were estimated from probit regressions, adjusting for age, gender, educational attainment, household income, administrative registration status, marital status, residential region, insurance status, chronic diseases diagnosis, and community-level clustering.
b Difference-in-difference estimate. *P < 0.05; **P < 0.01; ***P < 0.001.
